x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

The BioHub: The Top Voices in Biotech

Max Brennan - Biotech HeadHunter

Welcome to The BioHub, where the doors to the world of biotechnology swing wide open. Join your host, Max Brennan, a seasoned biotech recruiter, as he engages in thought-provoking conversations with the brightest minds in biotech. This podcast is your backstage pass to the insights, strategies, and stories that fuel success in the dynamic and ever-evolving biotech landscape. Subscribe now and be part of the conversation that"s shaping the future of biotechnology. Get ready for an immersive

science life sciences

All Episodes

00:27:41

Episode 65 - Robert Ross - CEO of Clasp Therapeutics

The BioHub: The Top Voices in Biotech ·

2025/09/04

We were delighted to welcome Robert Ross, Chief Executive Officer at Clasp Therapeutics, onto The BioHub. Clasp Therapeutics are a pioneering biotech company spearheading the next generation of T-cell engager therapies. Founded in 2024 and backed by a successful $150 million Series A round with top tier investors, Clasp stands out for its novel approach in delivering off-the-shelf, bispecific T‐cell engagers that narrowly target cancer-driving mutations while sparing healthy tissues. Dr. Ross brings

en

00:29:33

Episode 64 - Kristof Vercruysse - CEO of TargED...

The BioHub: The Top Voices in Biotech ·

2025/08/28

Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.On this episode we were joined by Kristof Vercruysse, CEO of TargED Biopharmaceuticals, an Utrecht-based biotech who're developing a novel Targeted Enzyme Delivery approach to Thrombolysis. On this episode, we discuss the current standard of care in indications such as TTP & Acute Ischemic Stroke and why TargED's platform represents a potential paradigm-shift for patients.

en

00:26:57

Episode 63 - Aaron Kantoff – Co-Founder of Scion Life...

The BioHub: The Top Voices in Biotech ·

2025/08/26

Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.I’m joined by Aaron Kantoff — Co-Founder and Managing Partner at Scion Life Sciences.Aaron helped build the therapeutics group at Apple Tree Partners from scratch, co-founding 11 companies along the way. After leaving Apple tree, Aaron co-founded RayzeBio, which was acquired by BMS for $4.1B.Now at Scion, he's continuing to back and build bold biotech companies with long-term potential — and a

en

00:15:22

Episode 62 - Alison Finger – COO Vicero Bio

The BioHub: The Top Voices in Biotech ·

2025/08/21

Today, we’re delighted to welcome Alison Finger, MBA, the Chief Operating Officer at Vicero Bio—a preclinical-stage biotech company pioneering VINCOBODY therapies, a next-generation nanobody platform being developed to tackle immune-mediated diseases and cancer. Since stepping into the COO role in September 2023, Alison has been at the helm of Vicero’s business operations, steering strategic and financial planning, company build-out, and business development initiatives.Prior to Vicero, Alison spent

en

00:32:47

Episode 61 - Rick Winningham – CEO Theravance

The BioHub: The Top Voices in Biotech ·

2025/08/14

Welcome to The BioHub podcast, where we interview the top minds from across the Biotech and Pharma industry.I’m joined by Rick Winningham, Chairman and CEO of Theravance Biopharma.Rick has led Theravance since its spin-out from Innoviva in 2014, after serving as CEO of Innoviva and holding senior leadership roles at Bristol Myers Squibb. He’s also been a driving force in industry advocacy, chairing the California Life Sciences Association and serving on the boards of Jazz Pharmaceuticals, Rivus, and

en

00:23:39

Episode 60 – Devyn Smith – CEO Arbor Biotechnologies

The BioHub: The Top Voices in Biotech ·

2025/07/31

Welcome back to another episoe of The Bio Hub, we were delighted to be joined by Dr. Devyn Smith, a widely respected executive and thought leader in the field of cell and gene therapy, with a career that spans both global pharmaceutical giants and pioneering biotech startups.Devyn is currently the Chief Executive Officer of Arbor Biotechnologies, a company at the forefront of next-generation gene editing, co-founded by CRISPR pioneer Feng Zhang. Arbor is developing a proprietary platform of

en

00:32:46

Episode 59 – Gerardo Ubaghs Carrion – CFO Frontier...

The BioHub: The Top Voices in Biotech ·

2025/07/31

Welcome to the BioHub podcast where we interview the top minds from across the Biotech and Pharma industry.I’m joined by Gerardo Ubaghs, CFO of Frontier Medicines. Gerardo has had one of the most unique career journeys you’ll hear — from being a professional violinist, to working in investment banking, and then stepping into biotech where he’s helped build and finance some of the most innovative companies out there. At Frontier, he’s driving strategy and finance for their mission to unlock

en

00:29:54

Episode 58– Dan Kemp (CEO) & Steven Katz- (CMO) of...

The BioHub: The Top Voices in Biotech ·

2025/07/29

Welcome back to another episode of The Bio Hub, we were delighted to be joined by two leaders from Shinobi Therapeutics, a company pushing the boundaries of off-the-shelf cell therapy through an innovative stealth cell platform that aims to overcome immune rejection and unlock the full potential of allogeneic CAR-T and CAR-NK therapies."With us is Dr. Dan Kemp, CEO of Shinobi Therapeutics. Dan brings over two decades of experience at the intersection of science and business in the cell and gene

en

00:15:37

Alex Blyth - CEO LifT Biosciences at BIO Boston 2025

The BioHub: The Top Voices in Biotech ·

2025/07/22

From BIO Boston: Alex Blyth, CEO of LifT BiosciencesIn this powerful opening episode from BIO 2025, I sit down with Alex Blyth, the founder and CEO of LifT Biosciences — a company re-engineering the immune system to finally beat cancer at its own game.We talk about:Why targeted therapies are failing most patientsWhat tumour escape is and why it’s the real enemyHow LiFt’s “super neutrophils” could be the Keytruda of innate immunityAnd the personal loss that pushed Alex to rethink everything we know

en

00:23:49

Episode 57– Jaideep Dudani - CEO Ouro Medicines

The BioHub: The Top Voices in Biotech ·

2025/07/22

Welcome to another episode of The Bio Hub. We were thrilled to welcome Jaideep Dudani, Founding CEO of Ouro Medicines and Portfolio Principal at Monograph Capital. Jaideep holds a PhD from MIT and a BS in Bioengineering from UCLA. Jaideep began his career at Vida Ventures and played key R&D, strategy, and business development roles at Relay Therapeutics. Jaideep later helped launch Human Immunology Biosciences (HI Bio), leading portfolio development and strategic initiatives prior to its

en

00:36:15

Episode 56– Alec Ford & Stacy Solorio - CEO and Chief...

The BioHub: The Top Voices in Biotech ·

2025/07/18

So welcome back to another episode of the Bio Hub, we were delighted to welcome Alec Ford (CEO of Karius) and Stacy Solorio (Chief people Officer at Karius). Alec is a veteran of the genomics and biotech industries with over 30 years of leadership experience. Alec is leading the charge in transforming infectious disease diagnostics through Karius’s groundbreaking liquid biopsy test, which uses microbial cell-free DNA and AI to detect over 1,000 pathogens from a single blood draw. Before joining

en

00:32:53

Episode 55– Dr Dan Williams - CEO SynaptixBio

The BioHub: The Top Voices in Biotech ·

2025/07/10

We were delighted to welcome Dr. Dan Williams, CEO and co-founder of SynaptixBio, a pioneering biotech company on a mission to develop life-changing treatments for children affected by devastating brain disorders, onto the bio hub. With over two decades of experience in the biotech and pharmaceutical industries, Dan has led teams from the lab bench to global clinical programs, and now he’s tackling one of the rarest and most challenging neurological diseases: TUBB4A-related leukodystrophies,

en

00:28:05

Episode 54– Adam Thomas - Chief People and Experience...

The BioHub: The Top Voices in Biotech ·

2025/07/09

We were delighted to welcome Adam Thomas, Chief People & Experience Officer at MOMA Therapeutics onto the Bio Hub, where he brings over two decades of strategic HR leadership across the biotech, pharmaceutical, and consumer industries. Since joining MOMA in 2024, Adam has led the company’s people and culture strategy during its pivotal transition into a clinical-stage organization, focusing on creating a world-class employee experience that integrates physical, digital, and cultural

en

00:09:10

Eamonn Hobbs- Founder, President & CEO of Syncromune...

The BioHub: The Top Voices in Biotech ·

2025/07/08

From BIO Boston: Eamonn Hobbs, CEO of SyncromuneEamonn Hobbs is a biotech veteran and serial CEO — and in this episode, he shares how Syncromune is rewriting the playbook for immunotherapy.We talk about:– How Syncromune’s SYNC-T platform delivered 87% ORR and 53% CR in mCRPC– What it means to synchronize drug, device, and immune response– Raising one of the few $100M Series A rounds in 2024– The mindset needed to build and win in today’s brutal marketEamonn’s clarity, experience, and grit shine

en

00:06:46

Spike Lo - VP Business Development of AP Bio at BIO...

The BioHub: The Top Voices in Biotech ·

2025/07/08

From BIO Boston: Spike Lo, VP of Business Development at AP BiosciencesIn this episode, I sit down with Spike Lo — a seasoned BD leader helping take AP Biosciences global.We dive into:— The rise of AP and their $96M raised to date— How their CD137-based T-cell engager platform is built for safety and precision— What sets Taiwan’s biotech ecosystem apart— Spike’s mindset on resilience, urgency, and global partnershipsA sharp conversation on building cross-border biotech with bold ambition.This

en

00:11:42

Josh Mandel-Brehm - CEO CAMP4 Therapeutics at BIO...

The BioHub: The Top Voices in Biotech ·

2025/07/07

Josh Mandel-Brehm, CEO of CAMP4 TherapeuticsIn this episode, I sit down with Josh Mandel-Brehm, the CEO of CAMP4 — a company pioneering a completely new approach in RNA therapeutics: upregulating gene expression using antisense oligonucleotides (ASOs).Josh shares the journey from a 5-person team to a publicly traded company, and how CAMP4’s platform is unlocking treatment for diseases previously out of reach — particularly in rare genetic and CNS disorders.We dive into:— What makes CAMP4’s approach

en

00:08:13

Jan Thirkettle - CEO Harness Therapeutics at BIO...

The BioHub: The Top Voices in Biotech ·

2025/07/07

From BIO Boston: Jan Thirkettle, CEO of Harness TherapeuticsIn this episode, I sit down with Jan Thirkettle, a biotech leader with deep experience across gene therapy, platform innovation, and company-building.Jan was part of the team that helped bring one of the first ex vivo gene therapies to market. Today, he’s leading Harness Therapeutics — a UK-based company developing a novel class of RNA therapeutics (SINEUPs®) to upregulate protein expression with unprecedented precision.We talk about:— Why

en

00:09:36

Adam Mendelsohn - CEO & Co-Founder Vivani Medical at...

The BioHub: The Top Voices in Biotech ·

2025/07/07

From BIO Boston: Adam Mendelsohn, CEO of Vivani MedicalIn this episode, I sit down with Adam Mendelsohn — bioengineer turned biotech CEO — and the co-founder of Vivani Medical.What started in a university basement has grown into a publicly listed company tackling one of the biggest challenges in healthcare: medication adherence.We talk about:— Building a biotech from scratch, and staying alive in tough times— Why GLP-1 implants could transform obesity and diabetes care— The mindset behind navigating

en

00:09:46

Steve Butts - CEO Arrivo Bio at BIO Boston 2025

The BioHub: The Top Voices in Biotech ·

2025/07/02

From BIO Boston: Steve Butts, CEO of Arrivo BioVenturesIn this episode, I sit down with Steve Butts — a five-time biotech founder and the CEO of Arrivo BioVentures.Steve has built and exited multiple companies, and now he's applying everything he’s learned to build Arrivo with precision: lean, capital-efficient, and structured for smart growth.We talk about:— How to build programs that big pharma wants— Why Arrivo structures its assets in separate subsidiaries— Navigating the current market as a

en

00:21:04

The BioHub - Avetix Podcast - S2 Ep53 - Lisa DiPaolo...

The BioHub: The Top Voices in Biotech ·

2025/06/26

Lisa DiPaolo is the Executive Vice President and Chief Human Resources Officer at Karyopharm Therapeutics, where she brings over two decades of HR leadership in the pharmaceutical and biotech industries. Since joining Karyopharm in September 2022, she has led the company’s People & Culture strategy through a critical period of growth and transformation. Before this, Lisa served as SVP of HR at Ipsen, overseeing North America as well as global R&D and Business Development, where she drove

en

131 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter